Joe A. Mccann is Chief Executive Officer of POINT Biopharma Global Inc.. Currently has a direct ownership of 0 shares of PNT, which is worth approximately $0. The most recent transaction as insider was on Dec 22, 2023, when has been sold 2,160 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

JOE A. MCCANN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
2,160 Reduced 100.0%
0 Common Stock
Nov 29 2022
BUY
Open market or private purchase
$14,342 $6.64 p/Share
2,160 Added 0.06%
3,616,313 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
3,614,153 Added 50.0%
3,614,153 Common Stock
JAM

Joe A. Mccann

Chief Executive Officer
Indianapolis, IN

Track Institutional and Insider Activities on PNT

Follow POINT Biopharma Global Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PNT shares.

Notify only if

Insider Trading

Get notified when an Point Biopharma Global Inc. insider buys or sells PNT shares.

Notify only if

News

Receive news related to POINT Biopharma Global Inc.

Track Activities on PNT